Odyssey
  • Homepage
  • Objectives
  • News
  • Publications
  • Privacy
    • Privacy Policy
    • Cookie Policy
  • Contact
  • Restricted
Select Page

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

by Communication Team | Aug 6, 2020 | Publication

Authors: Bollen PDJ, Moore C, Mujuru H, et al. The ODYSSEY Trial TeamPublished in: LANCET HIV. 2020;8:e533-e544 Download

Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years

by Communication Team | Mar 13, 2020 | Publication

Authors:  Waalewijn H, Mujuru HA, Amuge P, Cotton M, Bollen P, Chan M, Ali S, Variavan E, Makumbi S, Colbers A, Gibb D, Ford D, Burger D, Turkova A, and the ODYSSEY-trial teamPublished in: Oral presentation at 27th Conference on Retroviruses and Opportunistic...

Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years

by Communication Team | Mar 13, 2020 | Publication

Authors:  Waalewijn H, Mujuru HA, Amuge P, Cotton M, Bollen P, Chan M, Ali S, Variavan E, Makumbi S, Colbers A, Gibb D, Ford D, Burger D, Turkova A, and the ODYSSEY-trial teamPublished in: 27th Conference on Retroviruses and Opportunistic Infections, March 8th –11th,...

ODYSSEY: design, current status, and baseline characteristics

by Communication Team | Jan 27, 2020 | Publication

Authors: Moore CL,  Kekitinwa A, Kaudha E, et al; the ODYSSEY Trial TeamPublished in: 10th International Workshop on HIV Pediatrics, Amsterdam, July 20-21st, 2018. Poster Number 34 Download

Steady-state pharmacokinetics and early safety data in HIV-infected African children weighing 14 to <25kg on film-coated dolutegravir 25mg tablets

by Communication Team | Jan 27, 2020 | Publication

Authors: Bollen P, Turkova A, Hilda Mujuru H, et al. The ODYSSEY Trial TeamPublished in: 10th International Workshop on HIV Pediatrics, Amsterdam, 20-21st July 2018. Poster Number 22 Download

Adult dolutegravir 50mg film-coated tablets in children living with HIV weighing 20 to <25 kg

by Communication Team | Jan 27, 2020 | Publication

Authors: Bollen P, Turkova A, Mujuru H, et al. for the ODYSSEY Trial Team Published in: 26th Conference on Retroviruses and Opportunistic Infections, March 4th – 7th, 2019– Seattle. P_830 Download
« Older Entries

Recent Posts

  • Cheaper HIV treatment for children: a report in the Lancet
  • European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
  • ODYSSEY trial data published in Lancet – shows increase in treatment options for older children living with HIV
  • Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
  • Dolutegravir for Children living with HIV

Recent Comments

    Archives

    • December 2020
    • November 2020
    • August 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • August 2019
    • July 2019
    • March 2019
    • July 2018
    • June 2018
    • April 2018
    • August 2017
    • September 2016

    Categories

    • ODYSSEY
    • Publication

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    This study is funded by ViiV Healthcare and the sponsor is PENTA Foundation